Three-weekly docetaxel (T) plus capecitabine (X) in 1st and 2nd line metastatic esophageal cancer (MEC): Final results of the phase II DACAPO trial.

Document type:: Meeting Abstract
Author(s):: Lorenzen, S; Duyster, J; Lersch, C; Delius, S; Lang, B; Hennig, M; Bredenkamp, R; Peschel, C; Lordick, F
Title:: Three-weekly docetaxel (T) plus capecitabine (X) in 1st and 2nd line metastatic esophageal cancer (MEC): Final results of the phase II DACAPO trial.
Journal title abbreviation:: J Clin Oncol
Year:: 2005
Journal volume:: 23
Journal issue:: 16
Pages contribution:: 343S-343S
Language:: eng
Print-ISSN:: 0732-183X
TUM Institution:: II. Medizinische Klinik und Poliklinik (Gastroenterologie); III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie); Institut für Medizinische Statistik und Epidemiologie
BibTeX